Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Urogenital Neoplasms 1Sarcoma 1Nasopharyngeal Carcinoma 1Melanoma 1Lung Neoplasms 1Hearing Loss 1Colorectal Neoplasms 1Carotid Stenosis 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Cisplatin 127Gemcitabine 71Radiotherapy, Intensity-Modulated 61toripalimab 39Capecitabine 37Docetaxel 36Fluorouracil 35Radiotherapy 24camrelizumab 23Drug Therapy 22nimotuzumab 18spartalizumab 13pembrolizumab 13nedaplatin 12Chemoradiotherapy 12sintilimab 11apatinib 11Induction Chemotherapy 11Immune Checkpoint Inhibitors 11tislelizumab 10Nivolumab 10Magnetic Resonance Spectroscopy 10Specimen Handling 9Radiation 9Cetuximab 9Carboplatin 9endostar protein 8Paclitaxel 8Bevacizumab 8anlotinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × Atorvastatin × Head & Neck × Clear all
NCT02022293 2017-12-04

Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Suspended
324 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Carotid Stenosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡